The partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure in Ethiopia.
The bill aims to reduce barriers to the use of genetic and genomic testing, including for children on Medicaid with a suspected genetic disease.
The institute expects to announce its strategic plan in October 2020 to commemorate the 30th anniversary of the launch of the Human Genome Project.
Areas of concern are the recruitment of talented scientists, as well as retaining access to EU funding, European research collaborations, and clinical trials.
The agency aims to fund projects examining the ethical, legal, and social implications of human genome research.
The partners will explore the possibility of building a sequencing hub at the university for conducting local population cohort studies and diagnostic testing.
The new fund aims to advance data-driven innovations by investing in academic research on and the commercialization of genomic and other technologies.
Imagene will incorporate LifeNome's bioinformatics platform into consumer-facing genetic testing products to be marketed in China and Hong Kong.
The funding will support projects involving the use of genomic technologies to improve human health and agriculture, as well as to address key environmental challenges.
In a pair of papers, the researchers reported that the sugar pine genome largely comprises transposable elements and contains conifer-specific Dicer-like proteins.
An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.
The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.
Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.
In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.